Therefore, serum fetuin-B concentration could be proposed as a biomarker of NAFLD and might reflect the risk of development of liver steatosis at an early stage in PCOS women. The gene discussed is FETUB; the disease is metabolic dysfunction-associated steatotic liver disease.